tirzepatide shortage ending FDA sets compounding deadlines as ends So confused with Brello! :

Compounded tirzepatide is dispensed through state-licensed 503A pharmacies, meaning they are prepared for people with specific prescriptions (they are not mass-manufactured)

At week 20, the mean changes in body weight and WC were 6.4% and 5.0 cm for the semaglutide group, and 0.8% and 1.1 cm for the placebo group, respectively

When you see two different figures quoted for the same trial (for example, roughly 22.5% versus roughly 20.9% for tirzepatide 15 mg), the gap usually reflects which estimand is being cited, not a contradiction in the data

The reason for this variation almost always comes down to purity and documentation quality

Trimi's named 503A compounding pharmacy partners are VialsRx (Texas Board of Pharmacy license #35264) and GreenwichRx

Cancer Res (2014) 74(1):5667